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Background: p53 is a tumor suppressor that contributes to the host immune response against viral infections in
addition to its well-established protective role against cancer development. In response to influenza A virus (IAV)
infection, p53 is activated and plays an essential role in inhibiting IAV replication. As a transcription factor, p53
regulates the expression of a range of downstream responsive genes either directly or indirectly in response to
viral infection. We compared the expression profiles of immune-related genes between IAV-infected wild-type p53
(p53WT) and p53-deficient (p53KO) mice to gain an insight into the basis of p53-mediated antiviral response.
Methods: p53KO and p53WT mice were infected with influenza A/Puerto Rico/8/1934 (PR8) strain. Clinical
symptoms and body weight changes were monitored daily. Lung specimens of IAV-infected mice were collected
for analysis of virus titers and gene expression profiles. The difference in immune-related gene expression levels
between IAV-infected p53KO and p53WT mice was comparatively determined using microarray analysis and
confirmed by quantitative real-time reverse transcription polymerase chain reaction.
Results: p53KO mice showed an increased susceptibility to IAV infection compared to p53WT mice. Microarray
analysis of gene expression profiles in the lungs of IAV-infected mice indicated that the increased susceptibility was
associated with significantly changed expression levels in a range of immune-related genes in IAV-infected p53KO
mice. A significantly attenuated expression of Ifng (encoding interferon (IFN)-gamma), Irf7 (encoding IFN regulator
factor 7), and antiviral genes, such as Mx2 and Eif2ak2 (encoding PKR), were observed in IAV-infected p53KO mice,
suggesting an impaired IFN-mediated immune response against IAV infection in the absence of p53. In addition,
dysregulated expression levels of proinflammatory cytokines and chemokines, such as Ccl2 (encoding MCP-1), Cxcl9,
Cxcl10 (encoding IP-10), and Tnf, were detected in IAV-infected p53KO mice during early IAV infection, reflecting an
aberrant inflammatory response.
Conclusion: Lack of p53 resulted in the impaired expression of genes involved in IFN signaling and the dysregulated
expression of cytokine and chemokine genes in IAV-infected mice, suggesting an essential role of p53 in the regulation
of antiviral and inflammatory responses during IAV infection.* Correspondence: zhiyongma@shvri.ac.cn
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Table 1 Mice groups assigned for microarray analysis
Sampling 3 dpi Sampling 6 dpi
PR8-infection p53WT mice 3a 3
p53KO mice 3 3
Mock-infection p53WT mice 3 3
p53KO mice 3 3
dpi days post-infection
anumber of mice per group
Yan et al. BMC Medical Genomics  (2015) 8:52 Page 2 of 10Background
Influenza A virus (IAV) is a member of the Orthomyxo-
viridae family of RNA viruses and a primary cause of re-
spiratory tract infections that result in approximately
500,000 deaths per year worldwide [1]. IAV evokes the
host immune response to inhibit viral replication and
clear viral infections. Meanwhile, an aberrant host im-
mune response during IAV infection has been hypothe-
sized to be the main cause of IAV-related pneumonia.
The host immune response to IAV infection has been
extensively studied for more than 70 years; however,
many uncertainties still exist [2]. For example, host gene
involvement in both the host immune response and IAV
pathogenesis remain unclear [3, 4].
The p53 protein is a major tumor suppressor that
plays important roles in regulating various cellular ac-
tivities, including cell cycle arrest, DNA repair, senes-
cence, and apoptosis [5]. The p53 protein primarily
functions as a transcription factor that positively and
negatively regulates the expression of a large and dis-
parate group of responsive genes [6]. In addition to its
well-established role in protecting against cancer devel-
opment, p53 has been recently shown to contribute to
the host immune response against viral infections due
to vesicular stomatitis virus, Newcastle disease virus,
and hepatitis C virus [7–9]. The expression of p53 can
be induced at the transcriptional level by type I inter-
feron (IFN). The IFN-stimulated response elements
have been identified in p53 gene [7]. On the other
hand, p53 upregulates the expression of several IFN-
inducible proteins, including IFN regulatory factor
(IRF) 9, IRF5, IFN-stimulated gene 15, and toll-like re-
ceptor 3, suggesting a crosstalk between the p53 and
IFN pathways [10].
In response to IAV infection, p53 is significantly up-
regulated and activated in cultured cells [11–13] as well
as in the lungs of IAV-infected mice [14]. Previous stud-
ies indicated that p53 activation plays an essential role in
inhibiting IAV replication and regulating apoptosis of
IAV-infected cells [11, 15]. In this study, we observed in-
creased mortality, severe weight loss, and increased viral
loads in the lungs of p53-deficient mice after IAV infec-
tion, indicating an increased susceptibility to IAV. It is
known that p53, as a transcription factor, upregulates
or downregulates a series of immune-related genes ei-
ther directly or indirectly in response to viral infection
[10, 16]. To gain an insight into the basis of different
susceptibilities to IAV infection, we compared the ex-
pression profiles of immune-related genes in the lung
tissues of IAV-infected p53WT and p53 knockout
(p53KO) mice and found that a range of immune-
related genes involved in the regulation of host im-
mune and inflammatory responses showed significantly
altered expression levels in the absence of p53.Methods
Virus and mice infection
Influenza A/Puerto Rico/8/1934 (PR8) (H1N1 subtype)
virus was propagated in the allantoic cavities of 9-day-
old embryonated specific-pathogen-free (SPF) chicken
eggs. The lethal dose to 50 % (LD50) of the test animals
due to the PR8 virus was measured by intranasally in-
fecting p53WT C57BL/6 mice and calculated using the
method of Reed and Muench [17]. Homozygous p53+/+
(p53WT) and p53−/− (p53KO) mice on C57BL/6 back-
grounds were obtained from a breeding colony at the
SPF facility of the Shanghai Veterinary Research Institute
(Shanghai, China) by mating heterozygous p53+/− mice
originally obtained from the Jackson Laboratory (Bar
Harbor, ME, USA). For viral infection, 8 to 10-week-old
p53WT and p53KO mice (n = 10/group) were intrana-
sally inoculated with a sublethal dose (0.75 LD50/mouse)
of PR8 virus. Mock-infection of mice (n = 10/group) was
performed in an identical fashion to the viral infection
using inoculums of phosphate-buffered saline (PBS).
Clinical symptoms and body weight changes in PR8- and
mock-infected mice were monitored daily for 16 days.
Mice were euthanized upon a decrease in body weight
>25 % from the initial weight. The 50 % egg infectious
dose (EID50) in lung homogenates from PR8-infected
mice was determined in 10-day-old embryonated
chicken eggs and calculated using the method of Reed
and Muench [17]. All animal experiments were
performed in compliance with the Guidelines on the
Humane Treatment of Laboratory Animals (Ministry
of Science and Technology of the People’s Republic of
China, Policy No. 2006 398) and were approved by the
Institutional Animal Care and Use Committee at the
Shanghai Veterinary Research Institute.
Microarray analysis
Eight to 10-week-old p53WT and p53KO mice were ran-
domly assigned to eight groups, three mice per group
(Table 1). The mice were intranasally infected with a
sublethal dose of PR8 virus or mock-infected with PBS.
The PR8- and mock-infected mice were euthanized 3
and 6 days post-infection (dpi) to collect lung specimens.
Half of the collected lung samples was used to deter-
mine viral titers and the other half was processed for
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formed using the Affymetrix GeneChip Mouse Genome
430 2.0 Array (Affymetrix, Santa Clara, CA, USA), which
completely covers the Mouse Expression Set 430 and an-
alyzes over 39,000 transcripts on a single array. Sample
preparation and microarray experiments were performed
according to the manufacturer’s protocols. The data gener-
ated from the microarray experiments were analyzed using
the SBC Analysis System (http://www.ebioservice.com).
Bonferroni correction was used for multiple comparisons
between groups. The upregulation or downregulation
of more than 2-fold when PR8- and mock-infected mice
were compared, with Bonferroni-corrected p < 0.05, was
considered significant.
Quantitative real-time reverse transcription polymerase
chain reaction (qRT-PCR)
Total RNA was extracted from lung tissue using the
RNeasy Plus Mini Kit (Qiagen, Valencia, CA, USA) ac-
cording to the manufacturer’s protocol. The comple-
mentary DNA (cDNA) was synthesized using avian
myeloblastosis virus reverse transcriptase (TaKaRa, Otsu,
Japan). qRT-PCR analysis was performed using SYBR
Premix Ex Taq™ (TaKaRa) according to the manufac-
turer’s protocol. Briefly, total reaction volumes of 20 μl
were prepared containing 1 μl of cDNA, 10 μl of SYBR
Premix Ex Taq™ (2×), and 0.2 μM of specific primers.
The amplification parameters were an initial denatur-
ation step at 95 °C for 2 min followed by 40 cycles ofFig. 1 Increased susceptibility of p53KO mice to PR8 infection. p53WT and
sublethal dose of PR8 virus. Clinical signs and weight loss were assessed da
analysis of viral loads. a Weight loss analysis in PR8-infected mice. Results a
survival rates of PR8-infected mice. c Viral loads were determined by serial
eggs. The EID50 was calculated. d The expression of viral hemagglutinin (H
are means ± SE of at least 4 mice. *, p < 0.05 as assessed by the Student’s t15 s at 95 °C and 60 s at 60 °C. The primer sequences
are shown in Additional file 1: Table S1. Relative quan-
tification of gene expression was calculated using the
2-ΔΔCt method [18]. Data are presented as the fold
change (FC) in gene expression normalized to en-
dogenous glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and relative to the mock-infected mice.
Statistical analysis
All measured values are expressed as the mean ± standard
error (SE). The significance of the results was analyzed
using the Student’s two-tailed t-test or the Gehan-
Breslow-Wilcoxon test. A p value < 0.05 was considered
statistically significant.
Results
p53KO mice shows an increased susceptibility to IAV
infection
The p53WT and p53KO mice were intranasally inocu-
lated with a sublethal dose of PR8 virus and monitored
for 16 days. Mock infection of mice was performed in an
identical fashion to serve as controls. PR8-infected
p53KO mice displayed clinical signs of influenza (re-
duced activity, tachypnea, labored respiration, ruffled fur,
and increased weight loss) beginning 2 dpi, whereas
PR8-infected p53WT mice showed clinical signs begin-
ning 3 dpi. A significant difference in weight loss was
observed between PR8-infected p53WT and p53KO
mice 3–7 dpi (Fig. 1a). By 16 dpi, 63.6 % of PR8-infectedp53KO mice (n = 10 per group) were intranasally inoculated with a
ily for 16 days. Lungs of infected mice were collected 3 and 6 dpi for
re percentages of mean weight loss relative to initial weight. b The
titration of lung homogenates in 10-day-old embryonated SPF chicken
A) in the lungs of infected mice was determined by qRT-PCR. Values
-test; dpi, days post-infection
Table 2 Number of significantly changed genes
Regulation p53WTa p53WT vs p53KOb
3 dpi Up Total genes 964 508
Immune-related genes 275 94
Down Total genes 1016 579
Immune-related genes 236 135
6 dpi Up Total genes 987 639
Immune-related genes 320 193
Down Total genes 1258 861
Immune-related gens 279 184
anumber of significantly changed genes in PR8-infected p53WT mice compared
to mock-infected p53WT mice
bnumber of genes showing a significantly different expression between
PR8-infected p53WT and p53KO mice
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36.4 %), whereas 18.2 % of PR8-infected p53WT mice
died (survival rate 81.8 %) (p = 0.0222, as assessed by the
Gehan-Breslow-Wilcoxon test) (Fig. 1b). Viral loads in
the lungs of PR8-infected mice were analyzed 3 and 6
dpi by viral titration and qRT-PCR analysis. The virus
titer in lung homogenates from PR8-infected p53KO
mice was 107.5 EID50/ml, which was significantly higher
than the 105.8 EID50/ml in the lungs of PR8-infected
p53WT mice 3 dpi; however, no significant difference
was found between PR8-infected p53WT and p53KO
mice 6 dpi (Fig. 1c). These results were confirmed by
qRT-PCR analyses that examined the abundance of viral
hemagglutinin (HA) mRNA in lung homogenates of
PR8-infected mice. As shown in Fig. 1d, HA expression
was significantly higher in the lungs of PR8-infected
p53KO mice compared to PR8-infected p53WT mice 3
dpi, but not 6 dpi. These observations indicated that
p53-deficient mice had an increased susceptibility to
IAV infection and that p53 played an antiviral role
against IAV infection in vivo.
Global analysis of immune-related gene expression
between PR8-infected p53WT and p53KO mice
The p53 protein functions as a transcription factor that
regulates expression of a series of immune-related genes
in response to viral infection [10, 15, 16]. To explore the
basis of the susceptibility differences to IAV infection
between p53WT and p53KO mice, we compared expres-
sion profiles of immune-related genes in the lungs of
PR8-infected p53WT and p53KO mice. To this end, we
isolated RNA from lung homogenates of PR8- and
mock-infected mice 3 and 6 dpi and performed micro-
array analysis. The genes that showed significantly chan-
ged expression levels between PR8-infected p53WT and
p53KO mice are shown in Additional files 2: Table S2
and Additional file 3: Table S3. The possible functions of
these significantly changed genes were analyzed by Gene
Ontology (GO) analysis (Additional file 4: Figure S1).
A list of immune-related genes was obtained from the
Immunology Database and Analysis Portal (ImmPort)
System (https://immport.niaid.nih.gov), which contains
6005 gene entries (Additional file 5: Table S4). The num-
ber of immune-related genes that showed significantly
changed expression levels in PR8-infected p53WT mice
compared with their counterparts in mock-infected mice
is shown in Table 2. The FC of significantly altered ex-
pressions of immune-related genes in PR8-infected
p53WT mice was compared to that in PR8-infected
p53KO mice. Among 275 (3 dpi) and 320 (6 dpi) upreg-
ulated immune-related genes in PR8-infected p53WT
mice, 94 (3 dpi) and 193 (6 dpi) genes showed signifi-
cantly attenuated expression in PR8-infected p53KO
mice (Table 2, Additional file 6: Table S5). The possiblefunctions of these significantly attenuated immune-related
genes were analyzed by GO analysis. A considerable num-
ber (20 genes 3 dpi and 57 genes 6 dpi) of these genes
belonged to the GO category “immune system process”,
which were further classified into 11 sub-categories
(Table 3).
Out of 236 (3 dpi) and 279 (6 dpi) downregulated
immune-related genes in PR8-infected p53WT mice,
135 (3 dpi) and 184 (6 dpi) genes showed significantly
higher expression in PR8-infected p53KO mice than that
in PR8-infected p53WT mice (Table 2, Additional file 7:
Table S6). The GO analysis of the possible functions of
these differentially regulated genes indicated that only
12 genes 3 dpi and 10 genes 6 dpi belonged to the GO
category “immune system process” (Table 4), of which,
most were broadly classified into GO categories “biological
adhesion,” “growth,” “death,” “locomotion,” etc.
Impaired expression of immune-related genes involved in
IFN signaling pathways in the absence of p53
The IFN signaling pathway plays a key role in regulation
of immune response against IAV infection [19], therefore,
we compared the expression of immune-related genes in-
volved in IFN signaling between PR8-infected p53WT and
53KO mice. The products of IFN-stimulated genes (ISGs),
such as Mx, PKR, OAS, and tetherin, play a major role in
IFN-mediated antiviral responses against IAV infection
[19]. First, we compared the differences in the expression
of ISGs between PR8-infected p53WT and p53KO mice.
Among 924 ISGs analyzed (list of ISGs are available upon
request), 58 (3 dpi) and 66 (6 dpi) genes were significantly
upregulated in PR8-infected p53WT mice compared to
mock-infected mice, respectively (data are available upon
request). Among the upregulated ISGs, 13 were expressed
at a significantly attenuated level in PR8-infected p53KO
mice compared to PR8-infected p53WT mice (Table 5).
Remarkably, IFN-induced antiviral genes, including Mx2,
Oas2, Oas3, and Eif2ak2 (encoding protein kinase R
Table 3 GO analysis of genes with attenuated expression in PR8-infected p53KO mice






GO:0002684 Positive regulation of immune system
process
5 Ifng, Il2, Lag3, Stat6, Trat1 18 Blm, Lag3, Nfkbia, Il6, Fcer1g, Il15,
Ifng, etc.
GO:0002682 Regulation of immune system process 8 Il2, Lag3, Orm1, Ifng, Trat1, Hmgb1,
Jag1, Stat6
24 Blm, Orm1, Tnf, Nfkbia, Ifng, Tnfsf11,
etc.
GO:0050900 Leukocyte migration 2 Ifng, Il16 6 Tnf, Ifng, Fcer1g, Il1b, Selp, Tlr2
GO:0045321 Leukocyte activation 7 Fyn, Ifng, Il2, Lag3, Stat6, Exo1, Mink1 20 Lag3, Blm, Fcgr2b, Was, Nfkbid, etc.
GO:0019882 Antigen processing and presentation 2 Ctse, Ifng 5 Ifng, Fcgr2b, Fcer1g, Slc11a1, Ctse
GO:0001776 Leukocyte homeostasis 2 Ifng, Il2 6 Ifng, Fcer1g, Gpam, Ikbkb, Il6, Pik3cd
GO:0002252 Immune effecter process 6 Ifng, Il2, Lag3, Stat6, Exo1, Irf7 17 Irf7, Tnf, Lag3, Fcgr2b, Fcer1g, Msh2,
etc.
GO:0002253 Activation of immune response 1 Trat1 8 Nfkbia, Fcer1g, C1qb, Lat2, Plcg2,
etc.
GO:0002200 Somatic diversification of immune
receptors
4 Ifng, Il2, Stat6, Exo1 5 Ifng, Msh2, Cd40, Pms2, Exo1
GO:0002520 Immune system development 10 Hmgb1, Ifng, Il2, Jag1, Exo1, Tlx1, Six4 23 Blm, Timp1, Tnf, Tnfsf11, Cxcl13,
Msh2, etc.
GO:0006955 Immune response 13 Ctla4, Cxcl1, Ifng, Mx2, Irf7, Polr3c, etc. 47 Irf7, Cxcl9, Cxcl10, Ccl2, Ccl7, etc.
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factor 2-alpha kinase 2 (EIF2AK2)), Gbp1, Ifitm1, and
Bst2 (encoding tetherin, also known as bone marrow
stromal antigen 2), have been shown to possess anti-
IAV effects [19–23] and are expressed at significantly
attenuated levels in PR8-infected p53KO mice. Other
IFN-induced antiviral genes, such as Ifi44, Nampt,
Rtp4, Trex1, and Daxx [24, 25], have not yet been
found to restrict IAV replication, but have significantly
attenuated expression levels in PR8-infected p53KO
mice. The difference in the expression of Mx2, Eif2ak2,Table 4 GO analysis of genes significantly expressed in PR8-p53KO
GO ID Category 3 dpi
Number
of genes
GO:0002683 Negative regulation of immune system process 1
GO:0002682 Regulation of immune system process 1
GO:0031294 Lymphocyte costimulation 0
GO:0050900 Leukocyte migration 1
GO:0045321 Leukocyte activation 3
GO:0002684 Positive regulation of immune system process 0
GO:0001776 Leukocyte homeostasis 0
GO:0002252 Immune effector process 3
GO:0002200 Somatic diversification of immune receptors 2
GO:0002520 Immune system development 6
GO:0006955 Immune response 8Gbp1, Ifitm1, and Ifi44 between PR8-infected p53WT
and p53KO mice was confirmed by qRT-PCR (Fig. 2).
Antiviral genes play key roles in the host immune response
against IAV infection [19]. The impaired expression of
antiviral genes in the absence of p53 during IAV infection
was probably responsible for the high level of viral replica-
tion in the lungs of PR8-infected p53KO mice.
The expression of ISGs is mainly regulated by IFN at
the transcriptional level. The attenuated expression of
antiviral ISGs in the absence of p53 may result from






Il20rb 2 Cd80, Il7
1 Tgfb2
Ccl25 0
Msh2, Ndrg1, Il20rb 3 Ms4a1, Cd80, Il7
2 Cd80, Il7
1 Tgfb2
Il20rb, Msh2, Ung 0
Msh2, Ung 0
Chuk, Nfkb2, Pbx1, Six1, Msh2, Ung 7 Cebpa, Il7, Mb, Mlf1,
Med1, Six1, Tgfb2
Spon2, Bmi1, Il1rap, Msh2, Nfkb2,
Ccl25, Il20rb, Ung
2 Il7, Polr3g
Table 5 The expression of selected genes involved in interferon signaling pathway
Gene
symbol
Gene description FCa (p53WT/p53KO)
3 dpi 6 dpi
Mx2 myxovirus (influenza virus) resistance 2 42.94/14.54b 37.85/2.92b
Oas2 2'-5' oligoadenylate synthetase 2 14.75/12.43 13.20/3.06b
Oas3 2'-5' oligoadenylate synthetase 3 9.39/5.46 6.37/2.41b
Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 (PKR) 4.98/4.71 4.53/1.60b
Gbp1 guanylate binding protein 1 2.95/1.59 2.51/1.12b
Ifitm1 interferon induced transmembrane protein 1 2.50/2.32 2.58/1.24b
Bst2 bone marrow stromal cell antigen 2 (Tetherin) 3.41/2.22 2.96/1.02b
Ifi44 interferon-induced protein 44 4.59/2.82 2.98/1.09b
Nampt nicotinamide phosphoribosyltransferase 2.59/2.52 3.62/1.78b
Rtp4 receptor transporter protein 4 7.16/7.68 9.56/3.91b
Trex1 three prime repair exonuclease 1 6.72/11.63 8.32/2.98b
Daxx Fas death domain-associated protein 6.27/6.39 7.79/1.59b
Ifng interferon gamma 2.87/1.05b 6.07/0.90b
Ifnab interferon alpha B 1.80/0.80b 2.38/0.60b
Stat4 signal transducer and activator of transcription 4 1.78/0.79 2.08/0.80b
Stat6 signal transducer and activator of transcription 6 2.28/0.81b 1.87/0.34
Irf5 interferon regulatory factor 5 2.10/3.99 2.89/1.27b
Irf7 interferon regulatory factor 7 109.99/37.81b 93.18/7.18b
aFC fold change
bsignificant difference in gene expression between PR8-infected p53WT and p53KO mice
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PR8-infected p53WT and p53KO mice. Among IFN
and IFN receptor genes analyzed, only Ifng and Ifnab
were found to show a significantly attenuated expres-
sion in PR8-infected p53KO mice (Table 5). In addition,
the Jak-Stat signaling pathway, which is activated by
IFN, plays an essential role in the expression and activa-
tion of ISGs [26]. In the absence of p53, the expression
levels of Stat4 and Stat6 were attenuated significantlyFig. 2 Detection of gene expression in PR8-infected mice by qRT-PCR. Lu
subjected to qRT-PCR for expression analysis of the indicated genes. FC, f
PR8-infected p53WT and p53KO mice(Table 5). The difference in the expression levels of Ifng,
Stat4, and Stat6 between PR8-infected p53WT and
p53KO mice were confirmed by qRT-PCR (Fig. 2).
The IFN regulatory factors (Irf ) are essential for ex-
pression and regulation of IFN and ISGs [27]. Among 9
Irf genes analyzed, Irf1, Irf5, Irf7, and Irf9 were signifi-
cantly upregulated in PR8-infected p53WT mice com-
pared to mock-infected mice (data are available upon
request), especially, Irf7, which is the master regulator ofng samples were collected from PR8-infected mice 3 and 6 dpi and
old change. Results are means ± SE from 3 mice. *, p < 0.05 between
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nificantly upregulated in IAV-infected mice [29] with a
FC > 93 (Table 5). However, in PR8-infected p53KO
mice, although Irf7 was expressed at a significant level
compared to mock-infected p53KO mice, the FC was re-
markably less than that in PR8-infected p53WT mice,
showing significantly attenuated expression. Significantly
attenuated expression of Irf5 was also found 6 dpi in the
absence of p53 (Table 5). The difference in the expres-
sion levels of Irf5 and Irf7 between PR8-infected p53WT
and p53KO mice was confirmed by qRT-PCR (Fig. 2).
Taken together, a number of genes essential for regu-
lating IFN-mediated immune responses against viral in-
fection were expressed at significantly attenuated levels
in the absence of p53 during IAV infection, suggesting
that the IFN-mediated immune response against IAV in-
fection was impaired in the absence of p53.
Dysregulated expression of cytokine and chemokine
genes in the absence of p53
Viral infection results in the release of cytokines and
chemokines designed to recruit and shape innate and
adaptive immune responses. Unbalanced cytokine and
chemokine responses lead to uncontrolled inflammation
and unfavorable disease outcomes. In response to IAV
infection, a number of cytokines and chemokines are
significantly changed at the expression levels and play
important roles in immune responses against IAV infec-
tion as well as in IAV pathogenesis [15, 29–31]. Therefore,
we analyzed difference in expression levels of cytokines
and chemokines between PR8-infected p53WT and 53KO
mice. The cytokines, chemokines, and their respective re-
ceptors that were expressed with significant differences
between PR8-infected p53WT and 53KO mice are shown
in Table 6.
Of the 35 interleukin and respective receptor genes
analyzed, interleukin genes, such as IL1b, IL6, IL15, and
IL16, showed significantly attenuated expression levels 6
dpi, whereas most were expressed at relatively attenu-
ated levels 3 dpi in PR8-infected p53KO mice compared
with PR8-infected p53WT mice (Table 6). Analysis of
the expression levels of chemokines and their respective
receptor genes indicated that many were significantly
changed between PR8-infected p53WT and p53KO mice.
Notably, Ccl2 (encoding MCP-1), Cxcl9, and Tnf showed
remarkably higher expression levels 3 dpi and signifi-
cantly attenuated expression levels 6 dpi in PR8-infected
p53KO mice compared to PR8-infected p53WT mice
(Table 6). For instance, Ccl2, which is significantly
expressed in H5N1-infected primary human cells and in
IAV-infected highly susceptible mice [29, 32], showed an
upregulated expression 3 dpi in PR8-infected p53KO
mice with a FC of 130.8, which was 11-fold higher than
that (FC = 11.8) in PR8-infected p53WT mice, whereas itdisplayed attenuated expression 6 dpi in PR8-infected
p53KO mice with a FC of 9.89, which was 2.3-fold lower
than that (FC = 22.32) in PR8-infected p53WT mice.
Similar expression patterns were also observed for Ccl3,
Ccl7, Ccl11, Ccl19, Cxcl10, Cxcl13 and Cxcl14 (Table 6).
The differences in expression levels of IL1b, IL6, Ccl2,
Ccl19, Cxcl10, and Tnf between PR8-infected p53WT
and p53KO mice were confirmed by qRT-PCR (Fig. 2).
These observations suggested dysregulated expression of
cytokines and chemokines in the absence of p53 during
IAV infection.
Discussion
Tumor suppressor p53 is ubiquitously expressed in cells
and plays an important role in host defense against
tumor development. A growing body of evidence has in-
dicated that p53 is involved in regulation of immune re-
sponses against viral infections [7–10]. In this study, we
observed that p53-deficient mice infected with PR8 virus
showed increased mortality, severe weight loss, and
higher viral loads in the infected lungs compared to
PR8-infected p53WT mice (Fig. 1), suggesting that p53
was involved in host defense mechanisms against IAV
infection. These observations were in good agreement
with a previous description that p53 serves as a host
antiviral factor against IAV infection [15].
The major mechanism by which p53 functions is as a
transcription factor that regulates, both positively and
negatively, the expression of a large and disparate group
of responsive genes [6]. We comparatively analyzed the
global expression profiles of immune-related genes be-
tween IAV-infected p53WT and p53KO mice, which
could gain an insight into the basis of susceptibility dif-
ferences to IAV infection between p53WT and p53KO
mice. We observed that a number of immune-related
genes showed a significant change in expression levels
between PR8-infected p53WTand p53KO mice (Table 2).
Notably, a considerable number of genes that showed
significantly attenuated expression in PR8-infected
p53KO mice compared with PR8-infected p53WT mice
belonged to the GO category “immune system process”
(Tables 2 and 3). These data indicated that the expres-
sion of a range of immune-related genes was impaired in
the absence of p53 during IAV infection.
The IFN signaling pathway and especially, IFN-
induced antiviral genes, plays a key role in regulating the
immune response against IAV infection [19]. In this
study, we found that several anti-IAV genes, including
Mx2, Oas2, Oas3, Eif2ak2 (encoding PKR), Gbp1, Ifitm1,
and Bst2 (encoding tetherin) [19–23] and other antiviral
genes, including Ifi44, Nampt, Rtp4, Trex1, and Daxx
[24, 25] were expressed at significantly attenuated levels
in PR8-infected p53KO mice compared to PR8-infected
p53WT mice (Table 5). We thought that this impaired
Table 6 The expression of selected cytokine and chemokine genes
Gene
symbol
Gene description FCa (p53WT/p53KO)
3 dpi 6 dpi
Il1b interleukin 1 beta 2.30/3.71 2.85/0.93b
Il6 interleukin 6 3.27/2.79 2.52/0.95b
Il7 interleukin 7 0.65/0.47 0.34/0.83b
Il15 interleukin 15 2.64/1.72 2.05/0.67b
Il16 interleukin 16 4.93/0.15b 1.20/0.99
Il3ra interleukin 3 receptor, alpha chain 1.40/0.96 2.09/0.73b
Il10ra Interleukin 10 receptor, alpha (Il10ra), mRNA 3.04/3.16 4.14/1.21b
Il17rd interleukin 17 receptor D 0.48/0.41 0.07/0.45b
Il17re interleukin 17 receptor E 0.60/0.81 0.45/1.55b
Il20rb interleukin 20 receptor beta 0.27/0.98b 0.73/1.33
Ccl2 chemokine (C-C motif) ligand 2 (MCP-1) 11.83/130.82b 22.32/9.89b
Ccl3 chemokine (C-C motif) ligand 3 (MIP-1α) 7.90/11.23 9.62/1.90b
Ccl4 chemokine (C-C motif) ligand 4 (MIP-1β) 18.00/15.62 16.91/2.03b
Ccl7 chemokine (C-C motif) ligand 7 42.24/79.44 52.60/8.94b
Ccl11 chemokine (C-C motif) ligand 11 1.15/3.31 8.15/3.12b
Ccl19 chemokine (C-C motif) ligand 19 2.55/4.33 3.68/1.83b
Ccl25 chemokine (C-C motif) ligand 25 0.27/1.09b 0.58/1.53
Cxcl1 chemokine (C-X-C motif) ligand 1 21.07/6.71b 8.63/0.30b
Cxcl9 chemokine (C-X-C motif) ligand 9 39.58/120.08b 40.63/17.95b
Cxcl10 chemokine (C-X-C motif) ligand 10 (IP-10) 161.21/220.07 114.77/19.91b
Cxcl13 chemokine (C-X-C motif) ligand 13 2.48/10.71 7.60/1.71b
Cxcl14 chemokine (C-X-C motif) ligand 14 1.38/1.93 2.10/0.96b
Ccr6 chemokine (C-C motif) receptor 6 0.56/0.47 0.28/1.04b
Ccrl2 chemokine (C-C motif) receptor-like 2 2.89/2.26 2.35/0.82b
Tnf tumor necrosis factor 9.43/34.25b 8.90/1.06b
Tnfrsf10b tumor necrosis factor receptor superfamily, member 10b 0.46/2.18b 1.26/1.80
Tnfsf11 tumor necrosis factor (ligand) superfamily, member 11 0.27/0.08 5.88/1.81b
Tnfrsf8 tumor necrosis factor receptor superfamily, member 8 5.86/1.08b 0.88/0.01b
Tnfrsf18 tumor necrosis factor receptor superfamily, member 18 2.55/2.13 3.86/1.43b
aFC fold change
bsignificant difference in gene expression between PR8-infected p53WT and p53KO mice
Yan et al. BMC Medical Genomics  (2015) 8:52 Page 8 of 10expression of antiviral genes in the absence of p53 dur-
ing IAV infection was responsible for the high level of
viral replication in the lungs of PR8-infected p53KO
mice. In addition, the expression of several genes, such
as Irf7, Ifng, Stat4, and Stat6, which play important roles
in IFN-mediated immune response, was detected at sig-
nificantly attenuated levels in PR8-infected p53KO mice
(Table 5), suggesting that the IFN-mediated immune re-
sponse against IAV infection was impaired in the absence
of p53.
During IAV infection, unbalanced cytokine and chemo-
kine responses lead to uncontrolled inflammation and un-
favorable disease outcomes [31]. A comparison incytokine and chemokine expression levels between PR8-
infected p53WT and 53KO mice showed that several were
significantly different (Table 6), suggesting a dysregulated
cytokine and chemokine response in the absence of p53
during IAV infection. It is known that the upregulated ex-
pression of proinflammatory cytokines and chemokines,
including Ccl2 (encoding MCP-1), Ccl3 (encoding MIP-
1α), Ccl4 (encoding MIP-1β), Cxcl10 (encoding IP-10),
and Tnf, was observed during IAV infection and thought
to be associated with unfavorable disease outcomes [31],
such as the significant expression of Ccl2 in H5N1-
infected cells and in IAV-infected highly susceptible mice
[29, 32]. We observed that Ccl2 was upregulated 3 dpi
Yan et al. BMC Medical Genomics  (2015) 8:52 Page 9 of 10in PR8-infected p53KO mice with a FC of 130.8, which
was 11-fold higher than that in PR8-infected p53WT
mice (FC = 11.8) (Table 6). The p53 protein is a suppressor
of inflammation [33]. The upregulated expression of pro-
inflammatory cytokine and chemokine genes, such as
Ccl2, Ccl3, Cxcl9, Cxcl10, and Tnf, suggested aberrant in-
flammation conditions in PR8-infected p53KO mice dur-
ing early IAV infection and that the absence of p53 was
responsible for the upregulated expression.
In addition to inducing inflammatory responses, cyto-
kines and chemokines are immunological messengers
that play important roles in the development of innate
and adaptive immunity against IAV infection [31, 34].
For example, IFN-γ, the most important cytokine in
cell-mediated immunity, mediates expression of major
histocompatibility complex classes I and II and stimu-
lates antigen presentation and cytokine production
[34]. IFN-γ treatment at early stages of IAV infection
protects mice from death [35]. IL1b and IL6 play cru-
cial roles in the regulation of immune responses against
IAV infection. IL-1b-deficient mice infected with IAV
exhibited greater mortalities than wild-type mice [36].
IL-6 is involved in the development of influenza-
specific memory CD4 T cells [37]. Cxcl10 is a potent
chemoattractant for activated Th1 lymphocytes and
natural killer cells and is thought to play a role in the
temporal development of innate and adaptive immunity
in concert with type I and II IFNs [38]. We observed
that a range of cytokines and chemokines, such as Ifng,
IL-1b, Il6, Ccl2, and Cxcl10, showed significantly atten-
uated expression 6 dpi in PR8-infected p53KO mice
compared to PR8-infected p53WT mice (Tables 5 and 6).
The rapid decline in the expression of cytokine and che-
mokine genes in the absence of p53 might be associated
with an impairment of innate and adaptive immunity
against IAV infection.
Conclusions
Lack of p53 resulted in an increased susceptibility of
mice to IAV infection, which was associated with signifi-
cantly altered expression of a range of immune-related
genes in IAV-infected p53-deficient mice. The signifi-
cantly attenuated expression of Ifng, Irf7, and antiviral
genes, such as Mx2 and Eif2ak2, suggested an impaired
IFN-mediated immune response against IAV infection in
the absence of p53. On the other hand, dysregulated
expression of cytokines and chemokines, such as Ccl2,
Cxcl9, Cxcl10, and Tnf, has been observed, reflecting
aberrant inflammation conditions in p53-deficient mice
during early IAV infection. The impaired IFN-mediated
antiviral response and the aberrant inflammatory re-
sponse in the absence of p53 suggested an essential role
of p53 in the regulation of antiviral and inflammatory
responses during IAV infection.Additional files
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